Table 4 Differences in prescribed drugs for men in different BMI-categories: bivariate and multilevel analyses

Alimentary tract and metabolism (A)

14.0

16.9

25.2

p < 0.001

1.01

[0.83–1.22]

1.66*

[1.24–2.21]

Blood and blood forming organs (B)

9.2

14.2

13.3

p < 0.001

1.29*

[1.02–1.63]

1.23

[0.83–1.81]

Cardiovascular system (C)

14.6

25.2

32.1

p < 0.001

1.62*

[1.34–1.97]

2.81*

[2.09–3.77]

Dermatologicals (D)

18.9

22.1

26.3

p = 0.002

1.12

[0.95–1.32]

1.37*

[1.05–1.80]

Genito urinary system and sex homones (G)

3.3

4.5

3.3

ns

1.11

[0.78–1.58]

0.84

[0.43–1.64]

Systemic hormonal preparations (H)

3.7

4.5

8.0

p = 0.001

1.01

[0.73–1.42]

1.79*

[1.13–2.85]

Antiinfectives for systemic use (J)

21.6

27.5

32.4

p < 0.001

1.12

[0.95–1.31]

1.36*

[1.04–1.77]

Antineoplastic and immunomodulating agents (L)

0.4

0.4

0.6

ns

0.95

[0.33–2.75]

1.20

[0.24–5.98]

Musculoskeletal system (M)

14.3

20.8

30.2

p < 0.001

1.43*

[1.20–1.71]

2.18*

[1.67–2.85]

Nervous system (N)

14.8

18.2

21.6

p = 0.001

1.12

[0.94–1.35]

1.30

[0.97–1.74]

Antiparasitic products (P)

0.8

0.8

1.7

ns

0.96

[0.45–2.01]

2.16

[0.82–5.64]

Respiratory system (R)

15.8

18.6

23.0

p < 0.001

1.12

[0.94–1.33]

1.40*

[1.06–1.85]

Sensory organs (S)

7.9

8.6

9.4

ns

0.98

[0.77–1.25]

1.01

[0.67–1.51]